Patents by Inventor Winnie Chan

Winnie Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040126841
    Abstract: Human HL TEX11 polypeptides and DNA (RNA) encoding such HL TEX11 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such HL TEX11 for the treatment of atherosclerosis. inflammatory conditions. and infections. particularly viral infections such as AIDS. among others, among others. are also disclosed. Also disclosed are diagnostic assavs for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the HL TEX11 and for detecting altered levels of the polypeptide in a host.
    Type: Application
    Filed: February 19, 2003
    Publication date: July 1, 2004
    Applicant: SmithKline Beecham Corp.
    Inventors: Winnie Chan, Derk J. Bergsma, Catherine E. Ellis
  • Publication number: 20030148465
    Abstract: Human HL TEX11 polypeptides and DNA (RNA) encoding such HL TEX11 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such HL TEX11 for the treatment of atherosclerosis. inflammatory conditions. and infections. particularly viral infections such as AIDS. among others, among others. are also disclosed. Also disclosed are diagnostic assavs for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the HL TEX11 and for detecting altered levels of the polypeptide in a host.
    Type: Application
    Filed: February 19, 2003
    Publication date: August 7, 2003
    Applicant: SmithKline Beecham Corp.
    Inventors: Winnie Chan, Derk J. Bergsma, Catherine E. Ellis
  • Publication number: 20030082743
    Abstract: Human EDG-1c polypeptidees and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Human EDG-1c is identified as a selective receptor for sphingosine-1-phosphate (“S-1-P”) and for di-hydro S-1-P.
    Type: Application
    Filed: January 12, 2001
    Publication date: May 1, 2003
    Inventors: Derk J. Bergsma, Winnie Chan, Jonathan K. Chambers, Randall K. Johnson, Nassirah Khandoudi, George P. Livi, Phillipe Robert, Jeffrey M. Stadel, Pamela Joy Jensen, Shelagh Wilson
  • Patent number: 6423508
    Abstract: Human EDG-1c polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Human EDG-1c is identified as a selective receptor for sphingosine-1-phosphate (“S-1-P”) and for di-hydro S-1-P. Also diclsosed are methods for discovering agonists and antagonists of the interaction between S-1-P and di-hydro S-1-P and their cellular receptor, human EDG-1c, which may have utility in the treatment of several human diseases and disorders.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: July 23, 2002
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham PLC, SB Laboratories Pharmaceutiques
    Inventors: Derk J. Bergsma, Winnie Chan, Nassirah Khandoudi, Phillipe Robert
  • Publication number: 20020048790
    Abstract: Human HLTEX11 polypeptides and DNA (RNA) encoding such HLTEX11 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such HLTEX11 for the treatment of atherosclerosis, inflammatory conditions, and infections, particularly viral infections, such as AIDS, among others, among others, are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the HLTEX11 and for detecting altered levels of the polypeptide in a host.
    Type: Application
    Filed: June 13, 2001
    Publication date: April 25, 2002
    Inventors: Winnie Chan, Derk J. Bergsma, Catherine E. Ellis
  • Patent number: 5834587
    Abstract: Human HLTEX11 polypeptides and DNA (RNA) encoding such HLTEX11 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such HLTEX11 for the treatment of atherosclerosis, inflammatory conditions, and infections, particularly viral infections, such as AIDS, among others, among others, are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the HLTEX11 and for detecting altered levels of the polypeptide in a host.
    Type: Grant
    Filed: October 8, 1996
    Date of Patent: November 10, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Winnie Chan, Derk J. Bergsma, Catherine E. Ellis